Search

everythinglearnresearchcommunity

for

Search:↓

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Dermoscopy greatly improves melanoma diagnosis and reduces unneeded surgeries.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Benign follicular mucinosis involves immune cells attacking hair follicles.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.